Latest news with #Emami
Business Upturn
an hour ago
- Business
- Business Upturn
Procol's AI Platform Powers INR 1.5 Lakh Crore of India's Procurement, Sets Sights on Global Markets
By Business Wire India Published on July 30, 2025, 14:58 IST Procol, an AI-based procurement platform that automates processes and optimizes spending, proudly announces that over INR 1.5 lakh crore worth of procurement is now being managed through its platform Business Wire India Procol, an AI-based procurement platform that automates processes and optimizes spending, proudly announces that over INR 1.5 lakh crore worth of procurement is now being managed through its platform. This milestone reflects Procol's growing impact in transforming enterprise procurement, delivering innovative, efficient, and transparent solutions to over 150 enterprises across more than 10 countries. Procol's rapid growth stems from its strategic expansion into international markets, particularly the United States, where demand for modern procurement tools is surging. The company has diversified its customer base, now serving industries such as IT, e-commerce, quick-service restaurants, pharmaceuticals, and more, with prominent clients including Havells, Zepto, Bajaj Energy, Aditya Birla Group, Haldiram, and Emami. The launch of a cutting-edge Procure-to-Pay suite and AI-powered procurement agents has further accelerated adoption, enabling clients to streamline sourcing processes and achieve measurable cost savings. Procol's ascent is driven by targeted strategies, including a 4x surge in inbound demand through top rankings for procurement software keywords, exclusive roundtables uniting over 1,000 global procurement leaders, and partnerships with leading consulting firms like Kearney and Alvarez & Marsal. These efforts have solidified Procol's transition from a mid-market solution to a trusted enterprise partner, earning it a leadership position on G2 and recognition from top procurement strategy firms. The impact of Procol's platform is evident in the success stories of its clients. Signature Global reduced sourcing cycle times by 40%, Quippo Oil and Gas achieved 15% cost savings in logistics, and Emami enhanced digital procurement efficiency. These outcomes highlight Procol's ability to empower enterprises with faster, smarter, and data-driven procurement processes. Gaurav Baheti, Founder & CEO, Procol, said , 'Over INR 1.5 lakh crore worth of procurement is now run on Procol. This reflects a larger shift in the market. Procurement is no longer just a back-office function; it's emerging as a strategic lever for growth. We're excited to be part of this shift, and with AI agents, robust integrations, and more on the way, we're building a platform that truly empowers teams to do more with less.' Looking ahead, Procol aims to expand in the US and onboard more enterprise-level partnerships. By combining intuitive technology, strategic alliances, and a high-performing team, Procol is poised to redefine procurement excellence globally. Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash Business Wire India, established in 2002, India's premier media distribution company ensures guaranteed media coverage through its network of 30+ cities and top news agencies.
The Print
18-07-2025
- Business
- The Print
Emami tightens hold on pet care associate Cannis Lupus
According to a regulatory filing with stock exchanges on Thursday, Emami will convert existing inter-corporate loans of around Rs 8.23 crore into OCDs and infuse an additional Rs 4 crore through fresh subscription to these instruments. The Kolkata-headquartered company has executed an agreement to subscribe to Optionally Convertible Debentures (OCDs) issued by Cannis Lupus, which operates in the pet care segment under the brand 'Fur Ball Story'. Kolkata, Jul 17 (PTI) FMCG major Emami Ltd on Thursday said it will convert loans and make fresh investments in its associate company, Cannis Lupus Services, as part of its long-term growth strategy. The investment, the company said, aligns with its strategic focus on expanding into complementary wellness and lifestyle categories, though Cannis Lupus operates outside Emami's core FMCG business. Cannis Lupus, incorporated in 2019 and based in Gurugram, offers ayurvedic and herbal remedies for pets and is developing a portfolio of medicinal foods, supplements, and other pet care products. Its turnover stood at Rs 510 lakh in FY25, down from Rs 666 lakh in FY24. Emami has been gradually diversifying its portfolio in recent years through investments in wellness and healthcare adjacencies, including brands such as The Man Company, Brillare Science, and TruNativ. Shares of Emami closed at Rs 587.50 apiece on the NSE, up by 1.40 points or 0.24 per cent on Thursday. PTI BSM SBN SBN This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Economic Times
18-07-2025
- Business
- Economic Times
Newgen Software shares fall over 11% in two days after weak Q1 results
Shares of Newgen Software have dropped more than 11% over the past two sessions following the company's disappointing Q1FY26 earnings. On Friday, the stock fell nearly 6% to Rs 968 on BSE. ADVERTISEMENT Newgen Software reported a consolidated net profit of Rs 49.72 crore for the April–June quarter, marking a modest 4.5% year-on-year increase from Rs 47.57 crore. However, on a sequential basis, profit fell sharply by 54% from Rs 108 crore in Q4FY25. Revenue from operations grew just 2% YoY to Rs 321 crore but dropped over 25% compared to Rs 430 crore in the previous quarter. Also Read: Emami, Tube Investment among 10 mid-cap stocks analysts expect to gain up to 40% The company's operating performance also weakened. EBITDA declined 6% YoY to Rs 45 crore, while EBITDA margin narrowed to 14% from 15% a year ago. The decline was primarily attributed to higher employee benefit expenses and increased finance key markets, revenue from the India business showed a slight YoY increase but declined sharply from the March quarter. Revenue from Europe fell to Rs 103.4 crore from Rs 138.56 crore QoQ. ADVERTISEMENT APAC revenue remained flat YoY at Rs 49.9 crore but declined from Rs 69.2 crore in Q4FY25. Similarly, revenue from the US market was flat YoY but lower sequentially. Also Read: 9 undervalued mid-cap stocks with upside potential of up to 23% ADVERTISEMENT Newgen Software share price target According to Trendlyne, the average target price for Newgen Software is Rs 1,186, indicating a potential upside of nearly 22% from current levels. Of the four analysts tracking the stock, the consensus rating is 'Buy'. Also Read: SBI, Federal Bank among 11 banks that saw NPA improvement in Q4 (Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times) ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)
Time of India
18-07-2025
- Business
- Time of India
Newgen Software shares fall over 11% in two days after weak Q1 results
Shares of Newgen Software have dropped more than 11% over the past two sessions following the company's disappointing Q1FY26 earnings. On Friday, the stock fell nearly 6% to Rs 968 on BSE. Newgen Software Q1 performance Explore courses from Top Institutes in Select a Course Category Cybersecurity Data Analytics Digital Marketing Leadership Design Thinking Operations Management Degree CXO Management healthcare Finance MCA Project Management Data Science MBA Data Science Artificial Intelligence Public Policy others Healthcare Product Management Others Technology Skills you'll gain: Duration: 10 Months MIT xPRO CERT-MIT xPRO PGC in Cybersecurity Starts on undefined Get Details Newgen Software reported a consolidated net profit of Rs 49.72 crore for the April–June quarter, marking a modest 4.5% year-on-year increase from Rs 47.57 crore. However, on a sequential basis, profit fell sharply by 54% from Rs 108 crore in Q4FY25. Revenue from operations grew just 2% YoY to Rs 321 crore but dropped over 25% compared to Rs 430 crore in the previous quarter. Also Read: Emami, Tube Investment among 10 mid-cap stocks analysts expect to gain up to 40% The company's operating performance also weakened. EBITDA declined 6% YoY to Rs 45 crore, while EBITDA margin narrowed to 14% from 15% a year ago. The decline was primarily attributed to higher employee benefit expenses and increased finance costs. Among key markets, revenue from the India business showed a slight YoY increase but declined sharply from the March quarter. Revenue from Europe fell to Rs 103.4 crore from Rs 138.56 crore QoQ. APAC revenue remained flat YoY at Rs 49.9 crore but declined from Rs 69.2 crore in Q4FY25. Similarly, revenue from the US market was flat YoY but lower sequentially. Also Read: 9 undervalued mid-cap stocks with upside potential of up to 23% Newgen Software share price target According to Trendlyne, the average target price for Newgen Software is Rs 1,186, indicating a potential upside of nearly 22% from current levels. Of the four analysts tracking the stock, the consensus rating is 'Buy'. Also Read: SBI, Federal Bank among 11 banks that saw NPA improvement in Q4 ( Disclaimer : Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times)
News18
17-07-2025
- Business
- News18
Emami tightens hold on pet care associate Cannis Lupus
Kolkata, Jul 17 (PTI) FMCG major Emami Ltd on Thursday said it will convert loans and make fresh investments in its associate company, Cannis Lupus Services, as part of its long-term growth strategy. The Kolkata-headquartered company has executed an agreement to subscribe to Optionally Convertible Debentures (OCDs) issued by Cannis Lupus, which operates in the pet care segment under the brand 'Fur Ball Story'. According to a regulatory filing with stock exchanges on Thursday, Emami will convert existing inter-corporate loans of around Rs 8.23 crore into OCDs and infuse an additional Rs 4 crore through fresh subscription to these instruments. The investment, the company said, aligns with its strategic focus on expanding into complementary wellness and lifestyle categories, though Cannis Lupus operates outside Emami's core FMCG business. Cannis Lupus, incorporated in 2019 and based in Gurugram, offers ayurvedic and herbal remedies for pets and is developing a portfolio of medicinal foods, supplements, and other pet care products. Its turnover stood at Rs 510 lakh in FY25, down from Rs 666 lakh in FY24. Emami has been gradually diversifying its portfolio in recent years through investments in wellness and healthcare adjacencies, including brands such as The Man Company, Brillare Science, and TruNativ. Shares of Emami closed at Rs 587.50 apiece on the NSE, up by 1.40 points or 0.24 per cent on Thursday. PTI BSM SBN SBN (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: July 17, 2025, 20:45 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
